$CPSH
CPS TECHNOLOGIES CORP/DE/

2023 Q3 Form 10-Q Financial Statement

#000143774923022095 Filed on August 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q3
Revenue $7.418M
YoY Change 4.91%
Cost Of Revenue $5.222M
YoY Change -0.39%
Gross Profit $2.196M
YoY Change 20.1%
Gross Profit Margin 29.61%
Selling, General & Admin $1.465M
YoY Change 26.42%
% of Gross Profit 66.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $128.4K
YoY Change
% of Gross Profit 5.84%
Operating Expenses $1.465M
YoY Change 26.42%
Operating Profit $730.9K
YoY Change 9.18%
Interest Expense -$1.360K
YoY Change -185.53%
% of Operating Profit -0.19%
Other Income/Expense, Net $81.02K
YoY Change
Pretax Income $810.6K
YoY Change 20.79%
Income Tax $210.1K
% Of Pretax Income 25.92%
Net Earnings $600.5K
YoY Change 31.95%
Net Earnings / Revenue 8.1%
Basic Earnings Per Share $0.04
Diluted Earnings Per Share $0.04
COMMON SHARES
Basic Shares Outstanding 14.49M
Diluted Shares Outstanding 14.62M

Balance Sheet

Concept 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.681M
YoY Change 71.02%
Cash & Equivalents $8.681M
Short-Term Investments
Other Short-Term Assets $288.3K
YoY Change -8.03%
Inventory $4.814M
Prepaid Expenses
Receivables $5.075M
Other Receivables $0.00
Total Short-Term Assets $18.93M
YoY Change 29.74%
LONG-TERM ASSETS
Property, Plant & Equipment $1.508M
YoY Change 6.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.664M
YoY Change -32.98%
Total Long-Term Assets $3.572M
YoY Change -19.26%
TOTAL ASSETS
Total Short-Term Assets $18.93M
Total Long-Term Assets $3.572M
Total Assets $22.50M
YoY Change 18.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.360M
YoY Change 45.54%
Accrued Expenses $861.5K
YoY Change 7.0%
Deferred Revenue $1.828M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $56.68K
YoY Change 19.78%
Total Short-Term Liabilities $5.264M
YoY Change 24.55%
LONG-TERM LIABILITIES
Long-Term Debt $20.44K
YoY Change -73.5%
Other Long-Term Liabilities $273.3K
YoY Change -26.34%
Total Long-Term Liabilities $293.7K
YoY Change -34.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.264M
Total Long-Term Liabilities $293.7K
Total Liabilities $5.558M
YoY Change 18.89%
SHAREHOLDERS EQUITY
Retained Earnings -$23.07M
YoY Change
Common Stock $145.5K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.34M
YoY Change
Total Liabilities & Shareholders Equity $22.50M
YoY Change 18.34%

Cashflow Statement

Concept 2023 Q3
OPERATING ACTIVITIES
Net Income $600.5K
YoY Change 31.95%
Depreciation, Depletion And Amortization $128.4K
YoY Change
Cash From Operating Activities $1.555M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $257.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$257.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.38K
YoY Change
NET CHANGE
Cash From Operating Activities 1.555M
Cash From Investing Activities -257.0K
Cash From Financing Activities 13.38K
Net Change In Cash 1.311M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $1.555M
Capital Expenditures $257.0K
Free Cash Flow $1.298M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14546487
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14460486
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14511544
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14450470
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
34943
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
10016
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-07-01
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-16088
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2832509
dei Entity Address Address Line1
EntityAddressAddressLine1
111 South Worcester Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Norton
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02766-2102
dei City Area Code
CityAreaCode
508
dei Local Phone Number
LocalPhoneNumber
222-0614
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
dei Trading Symbol
TradingSymbol
CPSH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14516544
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8681225 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8266753 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5074559 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3777975 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39726851 usd
CY2023Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
74639 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
685668 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
4813753 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4875901 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
288315 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
211242 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
18932491 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
17817539 usd
CY2023Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
11028500 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
10770427 usd
CY2023Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
952883 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
952883 usd
CY2023Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
985649 usd
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
985649 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12967032 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12708959 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11699870 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11446901 usd
CY2023Q3 cpsh Construction In Progress Net
ConstructionInProgressNet
240415 usd
CY2022Q4 cpsh Construction In Progress Net
ConstructionInProgressNet
64910 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1507578 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1326968 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
400000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
466000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1664032 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2069436 usd
CY2023Q3 us-gaap Assets
Assets
22504101 usd
CY2022Q4 us-gaap Assets
Assets
21679943 usd
CY2023Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
56681 usd
CY2022Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
43711 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2359532 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1836865 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
861514 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
820856 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1828068 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2521128 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
158000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
157000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5263795 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5379560 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
20437 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
54847 usd
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
31277 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
231020 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
242000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
309000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
5557509 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5974427 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
145465 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
144605 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39978453 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23065388 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24125092 usd
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
111938 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
40848 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
16946592 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15705516 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22504101 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21679943 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7418138 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7070743 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14518405 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13723457 usd
CY2023Q3 us-gaap Revenues
Revenues
7418138 usd
CY2022Q3 us-gaap Revenues
Revenues
7070743 usd
us-gaap Revenues
Revenues
14518405 usd
us-gaap Revenues
Revenues
13723457 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5221880 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5242106 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10077444 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9931330 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
2196259 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1828637 usd
us-gaap Gross Profit
GrossProfit
4440961 usd
us-gaap Gross Profit
GrossProfit
3792127 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1465349 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1159157 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3015871 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2575550 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
730910 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
669480 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1425090 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1216577 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
79652 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1594 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
95242 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-319 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
810562 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
671074 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1520332 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1216258 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
210058 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
215966 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
460628 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
341714 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
600503 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
455108 usd
us-gaap Net Income Loss
NetIncomeLoss
1059704 usd
us-gaap Net Income Loss
NetIncomeLoss
874544 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14493970
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14431825
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14473128
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14410064
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14621929
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14708646
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14630765
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14682516
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16304653 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17316 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
24120 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
600503 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
16946592 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15705516 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
147757 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
33615 usd
us-gaap Net Income Loss
NetIncomeLoss
1059704 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
16946592 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
13848531 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39384 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8144 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6797 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
455108 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
14341676 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
13166311 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
163855 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17758 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
154724 usd
us-gaap Net Income Loss
NetIncomeLoss
874544 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
14341676 usd
us-gaap Net Income Loss
NetIncomeLoss
1059704 usd
us-gaap Net Income Loss
NetIncomeLoss
874544 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
252969 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
211641 usd
us-gaap Share Based Compensation
ShareBasedCompensation
147757 usd
us-gaap Share Based Compensation
ShareBasedCompensation
163855 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1296584 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-333048 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-611028 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-62148 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
754117 usd
cpsh Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
77073 usd
cpsh Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
87628 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
522667 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-478973 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
40658 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-438249 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-405404 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-341258 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-892803 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
835875 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
210784 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
433579 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
291631 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-433579 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-291631 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
33615 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
154724 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-17758 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
21439 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
30149 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12176 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
106817 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
414472 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25970 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8266753 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5050312 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8681225 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5076282 usd
us-gaap Interest Paid Net
InterestPaidNet
2902 usd
us-gaap Interest Paid Net
InterestPaidNet
4353 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
79456 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
79456 usd
us-gaap Stock Issued1
StockIssued1
71090 usd
us-gaap Stock Issued1
StockIssued1
18334 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
600503 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
455108 usd
us-gaap Net Income Loss
NetIncomeLoss
1059704 usd
us-gaap Net Income Loss
NetIncomeLoss
874544 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14493970
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14431825
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14473128
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14410064
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
600503 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
455108 usd
us-gaap Net Income Loss
NetIncomeLoss
1059704 usd
us-gaap Net Income Loss
NetIncomeLoss
874544 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14493970
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14431825
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14473128
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14410064
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
127959
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
276821
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
157637
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
272452
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14621929
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14708646
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14630765
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14682516
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2023Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
38000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
81000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
165000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
165000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
28000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
439000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
39000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
400000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
158000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
242000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
400000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P32Y
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.066 pure
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.66
CY2022Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.41
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
79000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
86000
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.20
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.22
CY2022Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
15300
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
88000
CY2022Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.44
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.97
CY2023Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
24642
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
24927
CY2022Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
3143
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
3983
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
754800
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.61
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M1D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
551000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.45
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1500000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1036400
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
294 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y11M1D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
17316 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
147757 usd
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
39384 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
163855 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2886278 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2645442 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1603511 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1863512 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
516889 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
525872 usd
CY2023Q3 us-gaap Inventory Gross
InventoryGross
5006678 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
5034826 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
192925 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
158925 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
4813753 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4875901 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
51489 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
35398 usd
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
685785 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
760305 usd
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
124240 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
25153 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
861514 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
820856 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
22272 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
46757 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
8090 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
77119 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
2902 usd
CY2023Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
179 usd
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
405 usd

Files In Submission

Name View Source Status
0001437749-23-022095-index-headers.html Edgar Link pending
0001437749-23-022095-index.html Edgar Link pending
0001437749-23-022095.txt Edgar Link pending
0001437749-23-022095-xbrl.zip Edgar Link pending
cpsh-20230701.xsd Edgar Link pending
cpsh20230630_10q.htm Edgar Link pending
ex_554201.htm Edgar Link pending
ex_554202.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
cpsh-20230701_cal.xml Edgar Link unprocessable
cpsh-20230701_pre.xml Edgar Link unprocessable
cpsh-20230701_def.xml Edgar Link unprocessable
cpsh-20230701_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cpsh20230630_10q_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending